Performance enhancing drugs and golf have had a pretty mundane connection for many years. However, as the money in the game continues to grow, the expectation that players will do anything necessary to get ahead has started to be proven true.
The latest example is Etienne Bond, a South African golfer playing on the Big Easy Tour. Bond was popped earlier this week for a failed drug test, resulting in a year-long suspension handed down by the Tour.
— Wayne Willmore™ (@Crazy_Willows) November 3, 2017
The Sunshine Tour has suspended a player for one year for failing a drug test, according to a report from Sport 24.
Etienne Bond, who primarily played the developmental Big Easy Tour in South Africa, failed a urine sample test for the use of Carvedilol. The drug is listed as a beta blocker and prohibited by the World Anti-Doping Agency.
WebMD says Carvedilol is used to treat high blood pressure and heart failure, and is often prescribed after heart attacks.
Bond did not have an exemption allowing him to use the drug. Beta blockers can be used by athletes to calm nerves and better handle pressure situations. After admitting use, he was suspended for 12 months, disqualified from 2017 events and removed from the Big Easy Tour’s Order of Merit.
Bond is currently ranked 1,929th in the Official World Golf Ranking.
Other notable anti-doping suspensions in the sport include Scott Stallings and Doug Barron on the PGA Tour.
— — —
Keep yourself up-to-date with the latest goings-on in the world of golf by following the SwingxSwing Clubhouse on social media. We share stories, stats and breaking news on Twitter, keep the fun going off the course on Instagram and share any and all golf-related topics on Facebook.
Never be the odd golfer out when your friends are talking about the latest or funniest happenings in golf. Sign up for the SxS newsletter today!